
|Articles|November 1, 2006
Breast cancer risk in subset of OC users
Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Minipad-based HPV testing shows promise for cervical cancer screening
2
Weekly review: Minipad HPV testing, ACOG statement, FAQs, and more
3
Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy
4
Study data highlight trade-offs of testing for pregnancy too soon
5









